FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention refers to areas of pharmacology and medicine and can be used for chemotherapy of tropical malaria caused by Plasmodium falciparum agent, especially in cases of its drug-resistant forms. Method of treating malaria involves administering a combination of preparations of Artemether and Iimatinib mesilate once a day in dosages of 0.33 mg/kg and 0.25 mg/kg respectively for three days.
EFFECT: method provides higher clinical effectiveness in malaria by overcoming drug resistance and reducing side effects of the drugs used.
1 cl, 1 tbl
Authors
Dates
2020-06-05—Published
2019-12-31—Filed